Abstract
Risperidone appears to be a significant advance in the treatment of schizophrenia. Its effectiveness for other serious psychiatric conditions, such as schizoaffective disorder and manic-depressive illness, has not been systematically studied. Further research is also needed to examine whether risperidone will be beneficial and adequately tolerated in special patient populations, including adolescents, the elderly, and psychiatric patients with concomitant medical illnesses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
